Insilico Medicine News and Activities

Insilico Medicine is a company listed under the stock ticker HKEX (US).

Acquisition, funding and merger involving Insilico Medicine.

• Insilico Medicine is now listed under ticker HKEX. (posted on January 20 2026).

View the org chart displaying its 21 main executives

Most searched biographies at Insilico Medicine

• Alex Zhavoronkov, Co-Chief Executive Officer and Chairman of the B...
• Denitsa Milanova, Director
• Roman Kyrychynskyi, Director

Popular executive movements at Insilico Medicine

• Halle Zhang has joined the company as Vice President, Clinical Development, Oncology  (posted on February 9 2026).
• Denitsa Milanova has joined the company as Director  (posted on February 9 2026).
• Sujata Rao, Chief Medical Officer, has left the company  (posted on September 17 2025).

Click here to view some more movements at Insilico Medicine

Create your alert
to follow the executive moves at Insilico Medicine.

Insilico Medicine has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Insilico Medicine

• Advancing Drug Discovery from Automation to Autonomy: Insilico Medicine Announces LabClaw the Intelligent System
• Insilico Medicine and Saudi Aramco Introduce the “Sanity Pipeline” to Advance AI-driven Discovery of MOFs
• Insilico Medicine to Present Groundbreaking AI Retrosynthesis Research at ICML 2026: Introducing ChemCensor to Bring Real-World Chemistry Into AI Benchmarking
• Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women’s Health
• Insilico Medicine named to Fast Company’s annual list of the world’s most innovative companies of 2026
• Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
• Insilico Medicine Launches PandaClaw: Empowering Biologists with Agentic AI for Therapeutic Discovery
• Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million
• Liquid AI and Insilico Medicine Announce Strategic Partnership Delivering Lightweight Scientific Foundation Models for Drug Discovery
• ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D
• View more press releases Close

Social media about Insilico Medicine

• Insilico Medicine on Wikipedia, Google News & Yahoo Finance
• Insilico Medicine on LinkedIn, X (Twitter) & YouTube